Tech Company Financing Transactions

Elcelyx Therapeutics Funding Round

Elcelyx Therapeutics closed a $4 million Series B venture capital round on 8/13/2012. Investors included Kleiner Perkins Caufield & Byers, Morgenthaler Ventures and Technology Partners.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

11995 El Camino Real 305
San Diego, CA 92130
USA

Phone

(858) 876-1814

Website

www.elcelyx.com

Email Address

[email protected]

Overview

40% of treated type 2 diabetes patients are not able to take metformin, the first-line and foundational therapy.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Alain Baron

        

Chief Financial Officer

Jay Sherwood

        

Chief Scientific Officer

Mark Fineman

        

VP - Regulatory Affairs

Thomas Bicsak

        

Browse more venture capital transactions:

Prev: 8/13/2012: Onconova Therapeutics venture capital transaction
Next: 8/13/2012: Relypsa venture capital transaction

Share this article

About Our VC Transactions Data

We do our best to record every notable VC transaction. All VC database entries reported here are sourced from a variety of public sources. The information is sourced from VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary